Jukka Peltola

Improving the effectiveness of ANT DBS therapy for refractory epilepsy 3:35
Improving the effectiveness of ANT DBS therapy for refractory epilepsy
Jukka Peltola • 29 Jun 2022
Clinical utility of hybrid video/audio-based epilepsy monitoring systems 4:01
Clinical utility of hybrid video/audio-based epilepsy monitoring systems
Jukka Peltola • 29 Jun 2022
What underlies the efficacy of thalamic DBS for drug-resistant epilepsy? 4:12
What underlies the efficacy of thalamic DBS for drug-resistant epilepsy?
Jukka Peltola • 29 Jun 2022
Optimizing DBS of the anterior nucleus of the thalamus in epilepsy 4:39
Optimizing DBS of the anterior nucleus of the thalamus in epilepsy
Jukka Peltola • 29 Jun 2022
Risks of DBS in epilepsy: are they irreversible? 2:43
Risks of DBS in epilepsy: are they irreversible?
Jukka Peltola • 29 Jun 2022
The content of VJNeurology is intended for healthcare professionals